Is Aimmune Therapeutics a Buy? [The Motley Fool]
AIMMUNE THERAPEUTICS (AIMT)
Last aimmune therapeutics earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aimmune.com/corporate-profile
Company Research
Source: The Motley Fool
Many investors and analysts alike were expectingAimmune Therapeutics(NASDAQ:AIMTHowever, Aimmune has suffered considerably so far this year. Shares have been on a steady decline, with the company losing about 60% of its value so far in 00. What does this mean for investors considering thisbiotech companyImage source: Getty Images.Solving the peanut-allergy problem?Peanut allergies are surprisingly common among people in developed countries. Some surveys suggest that about .% of U.S. children have some form of peanut allergy, making it one of the most common food allergies out there.Despite the prevalence of this problem among both children and adults, biotech companies have struggled to develop a drug that can successfully treat it. However, that all changed this January when Aimmune Therapeutics announced that its main candidate, Palforzia, had received FDA approval for patients between the ages of and 7 with confirmed peanut allergies.While the drug doesn't cure the allergies thems
Show less
Read more
Impact Snapshot
Event Time:
AIMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AIMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AIMT alerts
High impacting AIMMUNE THERAPEUTICS news events
Weekly update
A roundup of the hottest topics